U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07282665) titled 'A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older' on Dec. 05.
Brief Summary: The purpose of the study is to learn about how effective, safe, and tolerable the Clostridioides difficile (C. difficile) vaccine is in decreasing the number of C. difficile infections (pCDI) in adults 65 years of age or older.
The participants will receive either the C. difficile vaccine or placebo (saline). A placebo does not contain any active ingredients. The vaccines will be given as a shot into the upper arm muscle.
This study looks at the number of diarrhea (loose stools) events related to a C. difficile...